# Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy

> **NCT02115581** · PHASE4 · COMPLETED · sponsor: **University of Tehran** · enrollment: 38 (actual)

## Conditions studied

- Dilated Cardiomyopathy

## Interventions

- **DRUG:** Coenzyme Q10
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02115581
- **Lead sponsor:** University of Tehran
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2014-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02115581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02115581, "Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02115581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*